Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved
FTC sues OptumRx, rivals over insulin pricing
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
Zacks.com on MSN4h
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?
UnitedHealth Group Incorporated UNH is currently viewed as expensive, with the stock trading at a 19.09X forward 12-month ...
UnitedHealth Group Inc. stock underperforms Thursday when compared to competitors
UnitedHealth Group Inc. closed $30.87 below its 52-week high ($607.94), which the company achieved on September 4th.
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Modern Healthcare1d
UnitedHealth Group's Optum to lay off 160 employees
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
UnitedHealth Group Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Shares of UnitedHealth Group Inc. UNH inched 0.47% higher to $580.65 Wednesday, on what proved to be an all-around rough ...
UnitedHealth to Settle Wells Fargo 401(k) Funds Class Action
UnitedHealth Group Inc. struck a tentative deal to settle a class action challenging the Wells Fargo & Co. target date funds ...
UnitedHealth Group Incorporated (UNH): Best Forever Stock To Buy Now
We recently compiled a list of the 12 Best Forever Stocks To Buy Now. In this article, we are going to take a look at where ...
Home Health Care News1d
State Scrutiny Of UnitedHealth Group-Amedisys Deal Pushes Timeline Back Further
UnitedHealth Group’s (NYSE:UNH) acquisition of Amedisys (Nasdaq:AMED) is still pending. That could be due to a variety of factors, but one is clear: ...